Factors associated with quality of life in patients with severe asthma: the impact of pharmacotherapy

Daiane Silva Souza, Lúcia de Araújo Costa Beisl Noblat, Pablo de Moura Santos, Daiane Silva Souza, Lúcia de Araújo Costa Beisl Noblat, Pablo de Moura Santos

Abstract

Objective: To identify, characterize, and quantify associations of various factors with quality of life (QoL) in patients with asthma, according to the pharmacotherapy employed.

Methods: This was a cross-sectional study involving 49 patients (≥ 18 years of age) with severe uncontrolled or refractory asthma treated at a specialized outpatient clinic of the Brazilian Unified Health Care System, regularly using high doses of inhaled corticosteroids (ICs) or other medications, and presenting comorbidities. At a single time point, QoL was assessed with the Asthma Quality of Life Questionnaire (AQLQ). The overall AQLQ score and those of its domains were correlated with demographic variables (gender and age); Asthma Control Questionnaire score; pharmacotherapy (initial IC dose, inhaler devices, and polytherapy); and comorbidities.

Results: Better AQLQ scores were associated with asthma control--overall (OR = 0.38; 95% CI: 0.004-0.341; p < 0.001), "symptoms" domain (OR = 0.086; 95% CI: 0.016-0.476; p = 0.001), and "emotional function" domain (OR = 0.086; 95% CI: 0.016-0.476; p = 0.001)-and with IC dose ≤ 800 µg--"activity limitation" domain (OR = 0.249; 95% CI: 0.070-0.885; p = 0.029). Worse AQLQ scores were associated with polytherapy--"activity limitation" domain (OR = 3.651; 95% CI: 1.061-12.561; p = 0.036)-and number of comorbidities ≤ 5--"environmental stimuli" domain (OR = 5.042; 95% CI: 1.316-19.317; p = 0.015).

Conclusions: Our results, the importance of this issue, and the lack of studies taking pharmacotherapy into consideration warrant longitudinal studies to establish a causal relationship between the identified factors and QoL in asthma patients.

References

    1. Global Initiative for Asthma - GINA . Bethesda: Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2012. [2012 Oct 5]. Available from: .
    1. Cruz AA, Fernandes AL, Pizzichini E, Fiterman J, Pereira LF, Pizzichini M. Diretrizes da Sociedade Brasileira de Pneumologia e Tisiologia Para o Manejo da Asma--2012. J Bras Pneumol. 2012;38(Suppl 1):S1–S46.
    1. Solé D, Wandalsen GF, Camelo-Nunes IC, Naspitz CK. ISAAC - Brazilian Group Prevalence of symptoms of asthma, rhinitis, and atopic eczema among Brazilian children and adolescents identified by the International Study of Asthma and Allergies in Childhood (ISAAC) - Phase 3. J Pediatr (Rio J) 2006;82(5):341–346. doi: 10.1590/S0021-75572006000600006.
    1. Solé D, Melo KC, Camelo-Nunes IC, Freitas LS, Britto M, Rosário NA. Changes in the prevalence of asthma and allergic diseases among Brazilian schoolchildren (13-14 years old) comparison between ISAAC phases One and Three. J Trop Pediatr. 2007;53(1):13–21. doi: 10.1093/tropej/fml044.
    1. Ponte E, Souza-Machado A, Franco RA, Sarkis V, Shah K, Souza-Machado C, et al. Asthma and allergic rhinitis control program for state of Bahia (ProAr) a model for integration of health care, teaching and research [Article in Portuguese]. Rev Baiana Saude. Publica. 2004;28(1):124–132.
    1. Ponte EV, Souza-Machado A, Souza-Machado C, Franco R, Cruz AA. Clinical characteristics and prognosis in near-fatal asthma patients in Salvador, Brazil. J Bras Pneumol. 2011;37(4):431–437. doi: 10.1590/S1806-37132011000400004.
    1. Ponte E, Franco RA, Souza-Machado A, Souza-Machado C, Cruz AA. Impact that a program to control severe asthma has on the use of Unified Health System resources in Brazil. J Bras Pneumol. 2007;33(1):15–19. doi: 10.1590/S1806-37132007000100006.
    1. Seidl EM, Zannon CM. Quality of life and health: conceptual and methodological issues [Article in Portuguese]. Cad Saude Publica. 2004;20(2):580–588. doi: 10.1590/S0102-311X2004000200027.
    1. La Scala CS, Naspitz CK, Solé D. Quality of life in asthma How to evaluate it? [Article in Portuguese]. Rev Bras Alerg Imunopatol. 2004;27(6):217–230.
    1. Juniper EF, Buist AS, Cox FM, Ferrie PJ, King DR. Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest. 1999;115(5):1265–1270. doi: 10.1378/chest.115.5.1265.
    1. Silva LM, Silva LL. Validação do questionário de qualidade de vida em asma (Juniper) para o português brasileiro. Rev AMRGS. 2007;51(1):31–37.
    1. Mastalerz L, Kasperkiewicz H. Effect of inhaled corticosteroids on small airway inflammation in patients with bronchial asthma. Pol Arch Med Wewn. 2011;121(7-8):264–269.
    1. Small M, Anderson P, Vickers A, Kay S, Fermer S. Importance of inhaler-device satisfaction in asthma treatment real-world observations of physician-observed compliance and clinical/patient-reported outcomes. Adv Ther. 2011;28(3):202–212. doi: 10.1007/s12325-010-0108-4.
    1. Juniper EF, Wisniewski ME, Cox FM, Emmett AH, Nielsen KE, O'Byrnez PM. Relationship between quality of life and clinical status in asthma a factor analysis. Eur Respir J. 2004;23(2):287–291. doi: 10.1183/09031936.04.00064204.
    1. Pereira ED, Cavalcante AG, Pereira EN, Lucas P, Holanda MA. Asthma control and quality of life in patients with moderate or severe asthma. J Bras Pneumol. 2011;37(6):705–711.
    1. Juniper EF, O'Byrnez PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902–907. doi: 10.1034/j.1399-3003.1999.14d29.x.
    1. Gershon AS, Guan J, Wang C, Victor JC, To T. Describing and quantifying asthma comorbidity [corrected] a population study. PLoS One. 2013;7(5): doi: 10.1371/journal.pone.0034967.
    1. Cazzola M, Calzetta L, Bettoncelli G, Novelli L, Cricelli C, Roglian P. Asthma and comorbid medical illness. Eur Respir J. 2011;38(1):42–49. doi: 10.1183/09031936.00140310.
    1. Diniz JS, Ferreira F, Medeiros-Souza P, Santos-Neto LL, Silveira AN, Lowande TS. Brasil. Ministério da Saúde.Formulário Terapêutico Nacional 2010--Rename 2010. 2. Brasília: Ministério da Saúde; 2010. Medicamentos em idosos; pp. 41–44.
    1. Juniper EF, Bousquet J, Abetz L, Bateman ED. GOAL Committee Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. Respir Med. 2006;100(4):616–621. doi: 10.1016/j.rmed.2005.08.012.
    1. Ferreira LN, Brito U, Ferreira PL. Quality of life in asthma patients. Rev Port Pneumol. 2010;16(1):23–55. doi: 10.1016/S0873-2159(15)30005-2.
    1. Guyatt GH, Juniper EF, Walter SD, Griffith LE, Goldstein RS. Interpreting treatment effects in randomized trials. BMJ. 1998;316(7132):690–693. doi: 10.1136/bmj.316.7132.690.
    1. Lavoie KL, Bacon SL, Barone S, Cartier A, Ditto B, Labrecque M. What is worse for asthma control and quality of life depressive disorders, anxiety disorders, or both? Chest. 2006;130(4):1039–1047. doi: 10.1378/chest.130.4.1039.
    1. Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE. Measuring quality of life in asthma. Am Rev Respir Dis. 1993;147(4):832–838. doi: 10.1164/ajrccm/147.4.832.
    1. Delafuente JC. Understanding and preventing drug interactions in elderly patients. Crit Rev Oncol Hematol. 2003;48(2):133–143. doi: 10.1016/j.critrevonc.2003.04.004.
    1. Carvalho MF, Romano-Lieber NS, Bergsten-Mendes G, Secoli SR, Ribeiro E, Lebrão ML. Polypharmacy among the elderly in the city of São Paulo, Brazil - SABE Study. Rev Bras Epidemiol. 2012;15(4):817–827. doi: 10.1590/S1415-790X2012000400013.
    1. Maggiore RJ, Gross CP, Hurria A. Polypharmacy in older adults with cancer. Oncologist. 2010;15(5):507–522. doi: 10.1634/theoncologist.2009-0290.
    1. Bateman ED, Frith LF, Braunstein GL. Achieving guideline-based asthma control does the patient benefit? Eur Respir J. 2002;20(3):588–595. doi: 10.1183/09031936.02.00294702.
    1. Heyworth IT, Hazell ML, Linehan MF, Frank TL. How do common chronic conditions affect health-related quality of life. Br J Gen Pract. 2009;59(568):e353–e358. doi: 10.3399/bjgp09X453990.
    1. Choi JS, Jang AS, Lee JH, Park JS, Park SW, Kim DJ. Effect of high dose inhaled glucocorticoids on quality of life in patients with moderate to severe asthma. J Korean Med Sci. 2005;20(4):586–590. doi: 10.3346/jkms.2005.20.4.586.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner